180 related articles for article (PubMed ID: 2981241)
1. Glucocorticoid receptors and responsiveness of normal and neoplastic human adrenal cortex.
Kontula K; Pomoell UM; Gunsalus GL; Pelkonen R
J Clin Endocrinol Metab; 1985 Feb; 60(2):283-9. PubMed ID: 2981241
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of glucocorticoid receptors in the adrenal cortex: evidence for a direct dexamethasone suppressive effect on the rat adrenal gland.
Loose DS; Do YS; Chen TL; Feldman D
Endocrinology; 1980 Jul; 107(1):137-46. PubMed ID: 6247134
[TBL] [Abstract][Full Text] [Related]
3. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor.
Bourdeau I; Lacroix A; Schürch W; Caron P; Antakly T; Stratakis CA
J Clin Endocrinol Metab; 2003 Aug; 88(8):3931-7. PubMed ID: 12915689
[TBL] [Abstract][Full Text] [Related]
4. Plasma and salivary 6beta-hydroxycortisol measurements for assessing adrenocortical activity in patients with adrenocortical adenomas.
Varga I; Jakab C; Szücs N; Patócs A; Tóth M; Kiss R; Gláz E; Rácz K
Horm Metab Res; 2003 Jul; 35(7):421-6. PubMed ID: 12931273
[TBL] [Abstract][Full Text] [Related]
5. Presence of ectopic beta-adrenergic receptors on human adrenocortical cortisol-producing adenomas.
Hirata Y; Uchihashi M; Sueoka S; Matsukura S; Fujita T
J Clin Endocrinol Metab; 1981 Nov; 53(5):953-7. PubMed ID: 6270185
[TBL] [Abstract][Full Text] [Related]
6. Autocrine positive regulatory feedback of glucocorticoid secretion: glucocorticoid receptor directly impacts H295R human adrenocortical cell function.
Asser L; Hescot S; Viengchareun S; Delemer B; Trabado S; Lombès M
Mol Cell Endocrinol; 2014 Sep; 395(1-2):1-9. PubMed ID: 25058354
[TBL] [Abstract][Full Text] [Related]
7. Variable expression of the transcription factors cAMP response element-binding protein and inducible cAMP early repressor in the normal adrenal cortex and in adrenocortical adenomas and carcinomas.
Peri A; Luciani P; Conforti B; Baglioni-Peri S; Cioppi F; Crescioli C; Ferruzzi P; Gelmini S; Arnaldi G; Nesi G; Serio M; Mantero F; Mannelli M
J Clin Endocrinol Metab; 2001 Nov; 86(11):5443-9. PubMed ID: 11701720
[TBL] [Abstract][Full Text] [Related]
8. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
[TBL] [Abstract][Full Text] [Related]
9. [Measurement of cytoplasmic receptors specific for steroid hormones. IV) Glucocorticoid receptor].
Galli MC; Nanni P; De Giovanni C; Nicoletti G; Gobbi M
Boll Soc Ital Biol Sper; 1979 Feb; 55(3):195-9. PubMed ID: 553583
[TBL] [Abstract][Full Text] [Related]
10. A soluble glucocorticoid binding protein in the bovine adrenal cortex.
Cochet C; Job D; Dhien A; Chambaz EM
Arch Biochem Biophys; 1977 Apr; 180(1):1-9. PubMed ID: 558737
[No Abstract] [Full Text] [Related]
11. ACTH and prostaglandin receptors in human adrenocortical tumors. Apparent modification of a specific component of the ACTH-binding site.
Saez JM; Dazord A; Gallet D
J Clin Invest; 1975 Sep; 56(3):536-47. PubMed ID: 169292
[TBL] [Abstract][Full Text] [Related]
12. Melanocortin 2 receptor-associated protein (MRAP) and MRAP2 in human adrenocortical tissues: regulation of expression and association with ACTH responsiveness.
Hofland J; Delhanty PJ; Steenbergen J; Hofland LJ; van Koetsveld PM; van Nederveen FH; de Herder WW; Feelders RA; de Jong FH
J Clin Endocrinol Metab; 2012 May; 97(5):E747-54. PubMed ID: 22419722
[TBL] [Abstract][Full Text] [Related]
13. RU-26988--a new tool for the study of the mineralocorticoid receptor.
Gomez-Sanchez CE; Gomez-Sanchez EP
Endocrinology; 1983 Sep; 113(3):1004-9. PubMed ID: 6307658
[TBL] [Abstract][Full Text] [Related]
14. Binding characteristics of mineralocorticoid and glucocorticoid receptors in dog brain and pituitary.
Reul JM; de Kloet ER; van Sluijs FJ; Rijnberk A; Rothuizen J
Endocrinology; 1990 Aug; 127(2):907-15. PubMed ID: 2164924
[TBL] [Abstract][Full Text] [Related]
15. Increased neuroendocrine reactivity and decreased brain mineralocorticoid receptor-binding capacity in aged dogs.
Rothuizen J; Reul JM; van Sluijs FJ; Mol JA; Rijnberk A; de Kloet ER
Endocrinology; 1993 Jan; 132(1):161-8. PubMed ID: 8380372
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid-binding components in human thymus hyperplasia.
Ranelletti FO; Carmignani M; Iacobelli S; Tonali P
Cancer Res; 1978 Mar; 38(3):516-20. PubMed ID: 626957
[TBL] [Abstract][Full Text] [Related]
17. Direct inhibitory effect of dexamethasone on steroidogenesis of human adrenal in vivo.
Saito E; Ichikawa Y; Homma M
J Clin Endocrinol Metab; 1979 May; 48(5):861-3. PubMed ID: 219010
[TBL] [Abstract][Full Text] [Related]
18. Effect of adrenal manipulation on glucocorticoid receptors in MM1 hamster melanoma.
Stanberry LR; Lindsey WF; Beattie CW
Cancer Res; 1982 Jun; 42(6):2242-6. PubMed ID: 7074606
[TBL] [Abstract][Full Text] [Related]
19. Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease.
Chrousos GP; Vingerhoeds A; Brandon D; Eil C; Pugeat M; DeVroede M; Loriaux DL; Lipsett MB
J Clin Invest; 1982 Jun; 69(6):1261-9. PubMed ID: 6282933
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid receptors in adipose tissue.
Feldman D; Loose D
Endocrinology; 1977 Feb; 100(2):398-405. PubMed ID: 832631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
